I am 38 with A1AT deficiency. How to manage lung function?

Question

Hi doctor,

I am 38, diagnosed with alpha-1 antitrypsin deficiency after years of progressive shortness of breath, repeatedly misdiagnosed as adult-onset asthma by multiple doctors. Pulmonary function tests show very significant lung damage and emphysema changes for someone my age who has never smoked a single cigarette ever.

My pulmonologist wants to start weekly IV infusions of alpha-1 proteinase inhibitor replacement therapy, but it sounds incredibly time-consuming, extremely expensive, and there is no guarantee it will even help stop progression. I am absolutely terrified about developing severe emphysema and respiratory failure like my uncle did, who died at 56 from what we now realize was this same undiagnosed genetic condition.

My three young children desperately need genetic testing, but I am genuinely torn about burdening them with knowledge of a progressive, incurable disease for their entire lives. My work as a construction supervisor is becoming increasingly impossible because I get severely winded during any physical exertion, and the crew thinks I am just lazy or out of shape. My genetic counselor mentioned that serious liver cirrhosis problems can also develop, adding yet another frightening layer of worry about future health.

Sleep quality is progressively poor because I frequently wake up short of breath, and I am constantly anxious about progression speed.

Are there any promising newer treatments beyond weekly infusions or exciting gene therapy research for this rare condition? I desperately need to understand whether early aggressive treatment can truly significantly slow progression.

Please help.

Answer 1

Hi

Welcome to icliniq.com

I am very sorry you are facing this at such a young age.

Alpha-1 antitrypsin( A1AT) deficiency often stays hidden for years, and it is heartbreaking to find out only after the lungs have already been damaged. It makes complete sense that you feel afraid of ending up like your uncle and overwhelmed by the idea of lifelong treatment, work limitations, and the uncertainty about your children’s future.

None of this is your fault, and what you are feeling is very human. Weekly infusions of alpha-1 proteinase inhibitors are currently the only proven therapy that actually slows the progression of emphysema in people with severe deficiency. It does not reverse damage already done, but good studies show it can significantly delay further lung destruction. Many patients feel it gives them back a sense of control instead of watching their lungs worsen without intervention. Most infusion centers make the process less disruptive over time, and some patients eventually learn safe home-infusion programs.

There is genuine hope beyond infusions. Several new treatments are in development that aim to replace the missing protein with much longer-acting versions that would not require weekly infusions. There are active gene therapy trials where scientists insert a correct A1AT gene into liver cells so the body can make its own protective protein. Early results are encouraging, especially for younger patients, and this is one of the most promising research areas in rare lung disease.

There are also studies using ribonucleic acid (RNA)-based therapies to fix the faulty protein structure, which may become an option in the future. About your children, you are not burdening them by considering testing. Knowing early actually protects them because lifestyle changes, liver monitoring, and avoiding smoking or occupational hazards can dramatically reduce damage later in life. Many families find relief once they know, instead of living with fear and uncertainty.

I hope this answers your query. Kindly follow up if you have more doubts.

Thank you.